Steripath Micro Outside of the U.S.

We have plans to expand our Steripath® Initial Specimen Diversion Device® to several target international markets in the future. Once we finalize those target markets, we will follow up with you accordingly.

Thank you for your interest in Magnolia Medical Technologies,  and our mission to eliminate blood culture contamination and false positive diagnostic test results for sepsis! Please feel free to submit a request HERE and let us know what region you are in!